Physical Therapists in Valley City, ND Accepting Medicare
7 Physical Therapists found. Showing 1 - 7
 Dr. Lucas Reid Bopp, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 132 4th Ave Ne, Valley City, ND 58072 Phone: 701-845-8060 |
Michael G Bresnahan, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 570 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6400 |
 Sheyenne Valley Special Education Unit Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 232 3rd St Ne, Valley City, ND 58072 Phone: 701-845-3402 Fax: 701-845-3408 |
Grant J Goven, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 570 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6400 |
Mobilityplus Rehabilitation- Valley City Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1109 W Main St Ste B, Valley City, ND 58072 Phone: 701-678-2244 |
 Chrissie L Washburn, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 570 Chautauqua Blvd, Valley City, ND 58072 Phone: 701-845-6400 |
Encompass Family Support Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 202 Central Ave S Ste 2, Valley City, ND 58072 Phone: 701-478-1105 |
News Archive
Biomedical professor details research progress toward reading, writing neural code
Despite many remarkable discoveries in the field of neuroscience during the past several decades, researchers have not been able to fully crack the brain's "neural code."
Research may help advance search for more effective drugs to treat Alzheimer's disease
Two new studies published by investigators from Brigham and Women's Hospital illustrate that not all forms of amyloid-beta protein - the protein thought to initiate Alzheimer's disease - play an equally menacing role in the progress of the disease.
ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch
ScinoPharm, a leading active pharmaceutical ingredient (API) and contract research and manufacturing (CRAM) service provider to the global pharmaceutical and biotechnology industry, will provide commercial manufacturing service of vilazodone hydrochloride active pharmaceutical ingredient (API) for Clinical Data, Inc.'s Viibryd™, a new drug entity recently approved by the United States Food and Drug Administration.
Human antibody response to SARS-CoV-2
A new study published on the preprint server medRxiv* in August 2020 reports on the human antibody response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which is key to developing vaccines and managing the pandemic, as well as designing and executing serologic testing and interpreting their results.
NIH-funded clinical trial aims to restore vision in people who have lost vision due to IIH
In an NIH-funded clinical trial, led at Saint Louis University by professor of ophthalmology Sophia Chung, M.D., researchers aim to bring sight back to those who have lost vision due to idiopathic intracranial hypertension.
› Verified 1 days ago
Chiropractors
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Optometrists